Skip to content

Research on treatmens for inflammatory diseases using MSC-CM

Research on Treatments for Inflammatory Diseases Using Human-Derived Mesenchymal Stem Cell Conditioned Medium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051250159
Enrollment
100
Registered
2025-12-01
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory diseases inflamation, inflammatory disease

Interventions

None listed

Sponsors

Kato Yoichi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals who did not experience satisfactory treatment effects with standard therapy. 2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate. Inclusion criteria for patients are as follows: Patients meeting the following criteria are eligible: 1. Individuals aged 18 years or older. 2. Individuals with normal capacity to consent. 3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 4. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Individuals who meet any of the following conditions will be excluded: 1. Individuals who use narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

MeasureTime frame
- Conditions of the patient - Serum CRP levels as necessary

Countries

Japan, nose

Contacts

Public ContactYoichi Kato

Shin Yokohama Kato Clinic

kato@katoclinic.info+81-90-1725-1005

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026